Writing for The Atlantic, Ed Yong spotlights a study by MIT researchers that identifies a potential new treatment for Alzheimer’s – using pulses of light to stimulate brain waves. Yong writes that the study “heralds a completely new approach to dealing with Alzheimer’s—changing neural activity, rather than delivering drugs or chemicals.”
MIT researchers have found that exposure to flickering lights at a precise frequency may help fight off Alzheimer’s disease, reports Melissa Healy for The Los Angeles Times. The technique recruits “neurons and other cell types in the brain to sort of enable the brain’s inner ability to repair itself,” explains Prof. Li-Huei Tsai, director of the Picower Institute.
Guardian reporter Hannah Devlin writes about a new study by MIT researchers that shows that strobe lighting can reduce levels of toxic proteins found in Alzheimer’s disease. The researchers found that “exposure to flickering light stimulated brain waves, called gamma oscillations, that are known to be disturbed in Alzheimer’s patients.”
In an article for Popular Science, Kate Baggaley speaks with Prof. Timothy Lu and postdoc César de la Fuente about strategies they are developing to tackle antibiotic resistance. Lu explains that researchers are attempting to develop an arsenal of treatments to “be able to come at the problem from a variety of different ways.”
Straits Times reporter Nadia Chevroulet writes that researchers from MIT and the Singapore-MIT Alliance for Research and Technology (SMART) have uncovered how certain bacteria evade the body’s defenses. The findings could provide “new ways to counter tuberculosis, and possibly a new generation of drugs to battle antibiotic resistance.”
A paper-based test that can detect the Zika virus, developed by Prof. James Collins and his research team, is featured in a list of the year’s most important health innovations compiled Alyssa Favreau and Claire Maldarelli for Popular Science. Unlike conventional lab tests, the paper-based test can provide results within three hours.
Guardian reporter Amy Fleming spotlights Prof. Robert Langer’s work revolutionizing medicine. Fleming notes that “Langer’s trailblazing research in nanotechnology, which ranges from haircare to cancer treatments, has already improved the lives of at least 2 billion people.”
MIT researchers have developed a new technique for making vaccines using freeze-dried cells, reports Ed Yong for The Atlantic. Yong explains that in addition to producing medicines, the technique provides a new way of “detecting important diseases, like Zika and Ebola, without relying on laboratories or sequencing machines.”
Eric Boodman writes for STAT that MIT researchers have developed a technique to produce biopharmaceuticals in remote locations. “Instead of making the drugs and then trying to keep them refrigerated over thousands of miles,” Boodman writes, the researchers, “want to give people the ingredients. These components don’t require refrigeration, and the instructions are as simple as they come: Just add water.”
Prof. Robert Langer talks to Jessica Harris from NPR about his research on tissue engineering and drug delivery, the commercialization of his discoveries, and the many companies he has started. Langer says he started his lab based off his desire to improve people’s lives by conducting research “at the interface of chemical engineering and medicine.”
Angus Chen reports for NPR that MIT and Harvard researchers have captured footage showing bacteria invading antibiotics and transforming into superbugs. Postdoc Tami Lieberman explains that she hopes the visualization will help illustrate that “drug resistance is not some abstract threat. It's real."
MIT researchers have developed a new way to record the activities of human cells, reports Kevin Hartnett for The Boston Globe. “Most of the studies we do to understand diseases like cancer and Alzheimer’s involve studying cells in a dish. We’re interested in understanding how cells function in their natural environments,” explains Prof. Timothy Lu.
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a technique to record the history of human cells. “Much of our understanding of cancer is not reflective of what’s going on inside the patient,” explains Prof. Timothy Lu. “It’s only with tools like ours you can start testing those hypotheses.”
MIT researchers have developed a portable system that could produce biotech drugs on demand, reports Lisa Rapaport for Reuters. “The table-top machine has the potential to one day produce proteins to treat any number of a wide range of conditions like cancer, diabetes, heart attacks, and hemophilia,” writes Rapaport.
A portable device developed by MIT researchers uses programmable yeast to create drugs on demand, reports Jamie Ducharme for Boston Magazine. The device “could be a lifesaver for doctors working in vulnerable conditions, such as the battlefield, a remote village, or even an ambulance,” writes Ducharme.